Originals · Startup · Startups & Fintech
Rymo Technologies, which builds robotic and AI rehabilitation machines for smaller hospitals, gets backing from 1Crowd
The Navi Mumbai startup says its robots cost a fraction of imported systems that can run to Rs 1 to 1.5 crore, and the new investor joins eight months after a seed round of over Rs 10 crore.
Rymo Technologies, a Navi Mumbai based health technology startup that builds robots and AI software for physical rehabilitation, has added early stage fund 1Crowd as an investor. The deal was announced on 12 November in a 1Crowd release carried by PTI, and was reported the same day by BusinessLine and Dealroom. Neither the company nor the investor disclosed how much money is involved.
The problem Rymo is going after is cost. According to the 1Crowd note, imported robotic rehabilitation systems can cost between Rs 1 crore and Rs 1.5 crore, which puts them out of reach for most mid sized hospitals and physiotherapy clinics. Rymo says its own products cost 10 to 20 percent of what foreign competitors charge, and that they are designed for places with tighter budgets, less floor space and fewer trained therapists.
Its product range covers robotic rehabilitation systems, balance trainers and extended reality and virtual reality based therapy, with functional electrical stimulation devices on the way. The idea is to combine robotics, AI and game like exercises so that patients recovering from stroke, nerve or bone injuries get more consistent therapy, and so clinicians can track their progress with data instead of guesswork. Its flagship system is called Mobi-L.
This is not Rymo's first outside money. In March 2026 IAN Angel Fund led a seed round of over Rs 10 crore in the company, founded by Chirag Shah (CEO) and Abhishek Rai (CTO). At that time IAN said Rymo had more than 452 device installations and 354 clinical customers, including AIIMS, Apollo Hospitals and Manipal Hospitals, that it had received US FDA Class II medical device classification, and that it had signed a distribution partnership with Fourier Rehab to sell in ASEAN markets.
For 1Crowd, healthcare and medtech make up close to 20 percent of its portfolio, across about 10 companies. Co-founder and partner Natasha Kothari said the fund backs businesses that use technology to close gaps in access and delivery, and that Rymo stood out for making advanced rehabilitation technology more affordable for Indian healthcare providers.
